Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Industry: Pharmaceutical

Add a new term

Contributors in Cancer drugs

Become a Contributors

Cancer drugs

(18F)-labeled substance P antagonist receptor quantifier

Pharmaceutical; Cancer drugs

A radioconjugate consisting of the positron emitting radioisotope fluorine F 18 conjugated to the substance P antagonist receptor quantifier (SPA-RQ) used in radioimaging. (18F)-labeled substance P ...

lutetium Lu 177-DOTA-edotreotide

Pharmaceutical; Cancer drugs

A radioconjugate consisting of the octreotide derivative edotreotide (Tyr3-octreotide or TOC) labeled with lutetium Lu 177 with receptor ligand, beta-emitting radioisotope, and potential ...

Fluorine F 18 ISO-1

Pharmaceutical; Cancer drugs

A radioconjugate consisting of the benzamide ligand ISO-1 labeled with the radioisotope fluorine F18 with positron-emitting radioisotope activity. Upon administration, fluorine (F18)ISO-1 binds to ...

technetium Tc 94m sestamibi

Pharmaceutical; Cancer drugs

A radioconjugate consisting of sestamibi labeled with the positron-emitting isotope Tc 94m. Sestamibi is a synthetic molecule of the isonitrile family that diffuses through cell membranes and may ...

carbon C 13 dextromethorphan

Pharmaceutical; Cancer drugs

A radioconjugate consisting of dextromethorphan, a synthetic, methylated dextrorotatory analogue of levorphanol, conjugated with carbon-13 ((13)C) with radiotracer activity. (13)C-dextromethorphan ...

fluorine F 18 EF5

Pharmaceutical; Cancer drugs

A radioconjugate consisting of EF5, a fluorinated derivative of etanidazole, conjugated to fluorine F 18, a positron emitting isotope. EF5 binds to hypoxic tissue; conjugation to Fluorine F 18 allows ...

carbon C 14 PF-00299804

Pharmaceutical; Cancer drugs

A radioconjugate consisting of an orally bioavailable small-molecule inhibitor of the epidermal growth factor receptor (erbB or HER) family of tyrosine kinases radiolabeled with carbon-14 with ...